Clinical trial
Alternate Day Buprenorphine Administration, Phase X
NCT00000233 is registered in ClinicalTrials.gov with National Institute on Drug Abuse (NIDA) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Alternate Day Buprenorphine Administration, Phase X
- Lead sponsor
- National Institute on Drug Abuse (NIDA)
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- May 31, 1993
- Completion date
- Not reported
- Enrollment
- 0
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.